DJ Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ shed 3.08% to $1.26 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 1.57% to 26,541.35 and the Dow Jones Industrial Average rising 0.20% to 53,569.44.
The stock's fall snapped a three-day winning streak.
Inovio Pharmaceuticals Inc. closed 57.70% below its 52-week high of $2.98, which the company reached on September 9th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 1.57% to $265.77, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ fell 0.99% to $28.02.
Trading volume (2.3 M) remained 1.4 million below its 50-day average volume of 3.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 27, 2026.